ANIP ANI PHARMACEUTICALS INC Company Mergers 8-K Filing 2025 - Royalty Buy-Out On March 17, 2025, ANI Pharmaceuticals paid $17.25 million to SWK Funding LLC to buy out future royalty payments on ILUVIEN, effective from January 1, 2025, eliminating any further royalty obligations. This followed a letter agreement made on June 19, 2024, which set a lower fixed royalty payment of 3.125%.Get access to all SEC 8-K filings of the ANI PHARMACEUTICALS INC